Senanayake Chris's Form 4 filing
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · filed Mar 14, 2024
- Accession no.
- 0001493152-24-009980
- Filed
- Mar 14, 2024
- Trade date
- Dec 29, 2022
- Filing delay
- 441 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.62K. It was filed 441 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Senanayake ChrisCIK 0001945766 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2022 | COMMON STOCK | SSaleDisposed | −1,626 | $1.61 | −$2,617.86 | 2,791 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.